Neurosense Announces Third Quarter 2022 Financial Results And Provides Business Update
Neurosense Therapeutics Ltd 
NRSN:
NEUROSENSE THERAPEUTICS LTD - 9-MONTH LOSS PER SHARE $0.80
NEUROSENSE ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
NEUROSENSE THERAPEUTICS LTD - AS OF SEPTEMBER 30, 2022, NEUROSENSE HAD CASH AND SHORT-TERM DEPOSITS OF $8.44 MILLION
NEUROSENSE THERAPEUTICS LTD - BELIEVES THAT CASH RESOURCES WILL BE SUFFICIENT TO CONTINUE DEVELOPMENT OF CO'S PRODUCT INTO Q4 OF 2023